Search results
FDA approves Moderna’s mRNA RSV vaccine
The Hill via Yahoo News· 7 days agoThe Food and Drug Administration (FDA) has approved Moderna’s RSV mRNA vaccine for adults older than 60 years. The approval makes RSV ...
FDA Panel to Consider Which COVID Strain to Target in an Updated Vaccine
MedPage Today· 4 days agoIn the briefing document, the FDA staff gave a brief history of coronavirus vaccines, noting that...
FDA approves Moderna's RSV vaccine, its second marketed product
USA Today· 7 days agoFood and Drug Administration has approved Moderna's respiratory syncytial virus vaccine, the company...
FDA Panel to Consider Updating COVID-19 Jabs for New Virus Strains
Zacks via Yahoo Finance· 3 days agoAn FDA panel meeting is scheduled on Jun 5 to consider if COVID-19 vaccines should be updated to...
mRESVIA’s FDA approval paves the way for mRNA vaccines across multiple indications
Clinical Trials Arena via Yahoo Finance· 23 hours agoThis approval represents a significant development...vaccine to enter the US market following the...
Moderna secures a second FDA vaccine approval as Spikevax sales plummet
Fast Company Magazine· 7 days agoModerna announced on Friday that the U.S. Food and Drug Administration (FDA) has approved its...
Moderna (MRNA) Secures FDA Nod for mRNA-Based RSV Vaccine
Zacks via Yahoo Finance· 4 days agoThe RSV vaccine is Moderna???s (MRNA) second FDA-approved product. Once the vaccine secures the...
Moderna's RSV Vaccine Approved by FDA
Medscape· 4 days agoFor the first time, an mRNA vaccine has been approved for an indication other than COVID-19. The vaccine will join a couple other immunizations ...
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 7 days agoModerna stock sank Friday after the Food and Drug Administrationapproved its RSV vaccine, dubbed...
Adults 60+ Will Have 3 RSV Vaccines to Choose From This Year
Verywell Health via Yahoo News· 2 days agoThe FDA approved mRESVIA based on data from a clinical trial that included more than 35,000 adults...